US Bancorp
- SEC CIK
- 0000036104
- Latest filing
- Aug 12, 2026
NNVC holding history
Nanoviricides, Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NNVC overviewAll 13F holders of NNVCFull Q2 2026 holdings
- Shares (Q2 2026)
- 43
- Value
- $59
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 43 | $59 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 43 | $39 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 43 | $49 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 43 | $61 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 43 | $60 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 43 | $50 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 43 | $61 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 43 | $65 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 43 | $74 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 43 | $50 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 43 | $44 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 43 | $58 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 43 | $49 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 43 | $50 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 43 | $48 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 43 | $0 | 0.0% | −7−14.0% | Reduced | Holders |
| Q2 2022 | 50 | $0 | 0.0% | +7+16.3% | Added | Holders |
| Q1 2022 | 43 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q4 2021 | 43 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q3 2021 | 43 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q2 2021 | 43 | $0 | 0.0% | 00.0% | Unchanged | Holders |
| Q1 2021 | 43 | $0 | 0.0% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.